View Older Stories View More Recent Stories

Feb 5, 2025 06:25AM Leerink Partners Upgrades Regeneron Pharma (REGN) to Outperform
Feb 4, 2025 07:51PM ROSEN, LEADING TRIAL ATTORNEYS, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - REGN
Feb 4, 2025 04:06PM Regeneron Pharma (REGN) PT Lowered to $1,150 at Morgan Stanley
Feb 4, 2025 06:35AM Regeneron (REGN) Tops Q4 EPS by 80c
Feb 4, 2025 05:55AM REGN INVESTOR DEADLINE: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
Feb 3, 2025 07:46PM ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - REGN
Feb 3, 2025 02:36AM DEADLINE REMINDER: Berger Montague Reminds Regeneron Pharmaceuticals, Inc. (REGN) Investors of Important Class Action Lawsuit Deadline
Feb 2, 2025 07:46PM ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - REGN
Feb 2, 2025 07:46AM INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals
Feb 1, 2025 06:08PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - REGN
Jan 31, 2025 03:40PM ATTENTION REGENERON PHARMACEUTICALS, INC. (REGN) Shareholders: Securities Fraud Lawsuit Filed Against Regeneron Pharmaceuticals, Inc. (REGN)
Jan 31, 2025 07:30AM Regeneron Pharma (REGN) PT Lowered to $1,000 as Bernstein 'Expects EPS Miss Given Today's Dupixent Results'
Jan 30, 2025 08:21PM ROSEN, A LEADING LAW FIRM, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - REGN
Jan 30, 2025 02:25PM Regeneron Pharmaceuticals (REGN) Faces Securities Class Action After Losing $9 Billion Value Following Q3 2024 Earnings Report- Hagens Berman
Jan 29, 2025 08:21PM ROSEN, A TOP-RANKED LAW FIRM, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - REGN
Jan 29, 2025 07:08AM Regeneron Pharma (REGN) PT Lowered to $1,030 at TD Cowen
Jan 29, 2025 02:06AM Regeneron Pharmaceuticals (REGN) Investor Alert: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action
Jan 28, 2025 08:16PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - REGN
Jan 28, 2025 07:36PM INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals
Jan 28, 2025 06:26AM Regeneron Pharma (REGN) PT Lowered to $762 at Leerink Partners
Jan 27, 2025 06:18PM ROSEN, A LEADING LAW FIRM, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - REGN
Jan 27, 2025 07:48AM Regeneron Pharma (REGN) PT Lowered to $1,013 at Piper Sandler as Eylea HD Revenue Misses Consensus
Jan 27, 2025 02:06AM CLASS ACTION REMINDER: Berger Montague Advises Regeneron Pharmaceuticals, Inc. (REGN) Investors to Inquire About a Securities Fraud Lawsuit by March 10, 2025
Jan 26, 2025 03:00PM ROSEN, A TOP-RANKED LAW FIRM, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - REGN
Jan 26, 2025 07:35AM ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals
Jan 25, 2025 03:32PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - REGN
Jan 24, 2025 03:32PM ROSEN, LEADING INVESTOR COUNSEL, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - REGN
Jan 24, 2025 08:33AM REGN CLASS ACTION NOTICE: Berger Montague Encourages Regeneron Pharmaceuticals, Inc. (REGN) Investors to Inquire About a Securities Fraud Class Action
Jan 23, 2025 05:40PM REGN INVESTOR ALERT: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
Jan 23, 2025 03:26PM ROSEN, SKILLED INVESTOR COUNSEL, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - REGN
Jan 23, 2025 08:56AM Securities Class Action Allegations Cast Shadow Over Regeneron Pharmaceuticals (REGN)- Hagens Berman
Jan 23, 2025 02:36AM SHAREHOLDER ALERT: Berger Montague Reminds Regeneron Pharmaceuticals (NASDAQ: REGN) Investors of a Class Action Lawsuit Deadline
Jan 22, 2025 02:06AM REGENERON PHARMACEUTICALS SECURITIES FRAUD NOTICE: Berger Montague Informs Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) Investors of Securities Fraud Lawsuit
Jan 21, 2025 05:46PM ROSEN, A LEADING LAW FIRM, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - REGN
Jan 21, 2025 10:37AM Faruqi & Faruqi Reminds Regeneron Pharmaceuticals Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025 - REGN
Jan 20, 2025 11:17AM ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - REGN
Jan 19, 2025 04:00PM REGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Jan 18, 2025 01:17PM ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - REGN
Jan 18, 2025 07:52AM SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals
Jan 17, 2025 01:00PM ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - REGN
Jan 16, 2025 05:36PM DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals
Jan 15, 2025 09:57PM UBS Downgrades Regeneron Pharma (REGN) to Neutral
Jan 15, 2025 10:26AM Bernstein Reiterates Outperform Rating on Regeneron Pharma (REGN) Following a Sell-side Q&A
Jan 14, 2025 11:33AM Regeneron Pharmaceuticals, Inc. (REGN) Securities Fraud: Contact Berger Montague To Discuss Your Rights
Jan 14, 2025 04:59AM Goldman Sachs Reiterates Buy Rating on Regeneron Pharma (REGN)
Jan 13, 2025 11:25AM Regeneron Pharma (REGN) PT Lowered to $1,120 at Jefferies
Jan 13, 2025 11:15AM Truist Securities Reiterates Buy Rating on Regeneron Pharma (REGN)
Jan 13, 2025 07:41AM Regeneron (REGN) Provides Business Updates and Highlights from Broad Clinical Pipeline at the 43rd Annual J.P. Morgan Healthcare Conference
Jan 13, 2025 06:17AM Regeneron (REGN) Reports Adjuvant Libtayo Significantly Improves Disease-Free Survival (DFS) After Surgery in High-Risk Cutaneous Squamous Cell Carcinoma (CSCC) in Phase 3 Trial
Jan 13, 2025 06:08AM Regeneron (REGN) Collaborates with Truveta and Leading American Health Systems to Massively Extend its DNA Sequence-Linked Healthcare Database to Further Advance Scientific Innovation and Healthcare D
View More Recent Stories View Older Stories